| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $0.19 (Beat by $0.05) |
| EPS GAAP Actual | $0.19 (Beat by $0.05) |
| Revenue Actual | $0.474453B |
| Revenue Surprise | Beat by $474.453M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.17069 |
| EPS GAAP Estimate | $0.17069 |
| Revenue Estimate | $0.575695B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 0.98806 | 9.25 | 0.96385 | 1.00468 | 1 |
| Dec 2028 | 0.47899 | 19.08 | 0.47429 | 0.48238 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16 | 0.16 | 0.474453B | 15.09% | 474.45M |
| FQ2 2025 (Jun 2025) | -0.0079 | -0.0079 | 0.579B | 28.37% | 579M |
| FQ1 2025 (Mar 2025) | 0.12 | 0.12 | 0.517B | 26.64% | 517M |
| FQ4 2024 (Dec 2024) | 0.13 | 0.13 | 0.500003B | 28.02% | 500M |
| FQ3 2024 (Sep 2024) | 0.0169 | 0.0169 | 0.402853B | 100% | 402.85M |
| FQ2 2024 (Jun 2024) | -0.0016 | -0.0016 | 0.414746B | 100% | 414.75M |
| FQ1 2020 (Mar 2020) | 0.5 | 0.5 | 0.196542B | 100% | 196.54M |
| FQ2 2020 (Jun 2020) | 0.5 | 0.5 | 0.196542B | 100% | 196.54M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.17069
Consensus Revenue Estimates
0.575695B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.22375 | -- | 0.21502 | 0.2402 | 1 |
| FQ3 2027 (Sep 2027) | 0.25221 | -- | 0.24237 | 0.27075 | 1 |
| FQ2 2027 (Jun 2027) | 0.21057 | -- | 0.20236 | 0.22605 | 1 |
| FQ1 2027 (Mar 2027) | 0.19176 | -- | 0.18428 | 0.20586 | 1 |
| FQ4 2026 (Dec 2026) | 0.21528 | -- | 0.20688 | 0.23111 | 1 |
| FQ3 2026 (Sep 2026) | 0.20361 | 21.42 | 0.19567 | 0.21858 | 1 |
| FQ2 2026 (Jun 2026) | 0.17322 | 104.56 | 0.16646 | 0.18596 | 1 |
| FQ1 2026 (Mar 2026) | 0.17069 | 29.7 | 0.16403 | 0.18324 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.7B | -- | 0.68B | 0.74B | 2 |
| FQ3 2027 (Sep 2027) | 0.67B | -- | 0.65B | 0.71B | 2 |
| FQ2 2027 (Jun 2027) | 0.69B | -- | 0.67B | 0.73B | 2 |
| FQ1 2027 (Mar 2027) | 0.64B | -- | 0.62B | 0.67B | 2 |
| FQ4 2026 (Dec 2026) | 0.64B | -- | 0.62B | 0.68B | 2 |
| FQ3 2026 (Sep 2026) | 0.61B | 21.68 | 0.59B | 0.64B | 2 |
| FQ2 2026 (Jun 2026) | 0.61B | 5.19 | 0.59B | 0.65B | 2 |
| FQ1 2026 (Mar 2026) | 0.58B | 10.2 | 0.56B | 0.6B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.16 | 0.16 | 100% | |
| FQ2 2025 (Jun 2025) | -0.0079 | -0.0079 | 100% | |
| FQ1 2025 (Mar 2025) | 0.12 | 0.12 | 100% | |
| FQ4 2024 (Dec 2024) | 0.13 | 0.13 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0169 | 0.0169 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0016 | -0.0016 | 100% | |
| FQ1 2020 (Mar 2020) | 0.5 | 0.5 | 100% | |
| FQ2 2020 (Jun 2020) | 0.5 | 0.5 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.47B | $474.45M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.58B | $579M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.52B | $517M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.5B | $500M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.4B | $402.85M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.41B | $414.75M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0.2B | $196.54M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.2B | $196.54M | 100% |